IP Library › Assignment 033353/0054
Patent Assignment
Reel/Frame 033353/0054

Merger

Recorded: 2014-07-21 Pages: 13
Assignor
ESBATECH AG
Executed: 2009-09-11
Assignee
DELENEX THERAPEUTICS AG
WAGISTRASSE 21, SCHLIEREN, CH-8952, SWITZERLAND
Covered Property (1)
Method for Treating Glioblastoma Using Antibodies Binding to the Extracellular Domain of the Receptor Tyrosine Kinase Alk
Patent: 8,945,563 →
Application: 13/017,925 →
Publication: US 2011/0159008
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 21, 2014
From: AUF DER MAUR, ADRIAN; BARBERIS, ALCIDE; LICHTLEN, PETER
To: ESBATECH AG
Reel/Frame 033352/0916 →
Change of Name Aug 8, 2016
From: DELENEX THERAPEUTICS AG
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 039629/0573 →